Ezzat El Hassadi, MD, University Hospital Waterford, Waterford, Ireland, outlines the challenges associated with treatment sequencing in multiple myeloma, commenting on the remarkable efficacy of CAR-Ts in this setting, and highlighting the possibility to incorporate CAR-T therapy earlier in the treatment algorithm of multiple myeloma. This interview was recorded virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
